Tobacco Remains Primary Driver as Gujarat Sees Steady Five-Year Rise in Lung Cancer Cases

AHMEDABAD, India — Lung cancer registrations at the Gujarat Cancer and Research Institute (GCRI) have risen steadily over the past five years, climbing from 813 cases in 2021 to 1,133 in 2025. The new institutional data, released in conjunction with World Lung Cancer Day observances, highlights a growing public health challenge in western India where tobacco use remains the primary preventable risk factor, even as non-smoking factors increasingly demand attention.

According to the GCRI report, a total of 4,830 lung cancer patients were registered at the institute between 2021 and 2025. While men accounted for 81.4% of these cases (3,931 patients), health authorities emphasize that the remaining 18.6% (899 cases) among women underscores a vital message: lung cancer is not exclusively a smoker’s disease.

What the Five-Year Data Shows

The regional increase documented by GCRI reflects a persistent, upward trajectory in respiratory oncology cases across the state’s leading tertiary cancer center.

GCRI Annual Lung Cancer Registrations (2021–2025)
┌──────┬──────────────────────────┬────────┐
│ Year │ Registered Patient Count │ Change │
├──────┼──────────────────────────┼────────┤
│ 2021 │ 813                      │ Base   │
│ 2022 │ 865                      │ +6.4%  │
│ 2023 │ 933                      │ +7.9%  │
│ 2024 │ 1,086                    │ +16.4% │
│ 2025 │ 1,133                    │ +4.3%  │
└──────┴──────────────────────────┴────────┘
Total 5-Year Registrations: 4,830

These figures fit into a larger national and global picture. GLOBOCAN estimates indicate that India records more than 112,000 new lung cancer cases and over 98,000 deaths annually. Worldwide, the World Health Organization (WHO) identifies lung cancer as the leading cause of cancer incidence and mortality, accounting for approximately 2.5 million new cases and 1.8 million deaths each year.

“The steady uptick in hospital registrations mirrors both a real demographic burden and improving clinical capture,” explains Dr. Rajesh Sundaram, an independent epidemiological researcher not affiliated with the GCRI study. “As populations age and diagnostic imaging becomes more accessible, we naturally detect more cases. However, the underlying driver in the vast majority of male patients remains direct tobacco exposure.”

Tobacco Burden and Emerging Environmental Factors

Tobacco consumption—including cigarettes, bidis, and smokeless variants—remains the principal cause of lung malignancy in India. A comprehensive 2025 analysis published in PLOS One revealed that tobacco-related tracheal, bronchus, and lung cancer deaths among Indian men nearly doubled over two decades, rising from 16,041 in 2000 to 29,577 in 2021. Among women, deaths rose from 1,653 to 3,970 over the same period.

While direct smoking dominates male statistics, public health researchers emphasize that non-smoking risk factors play a disproportionate role in female diagnoses. A landmark review in the South Asian Journal of Cancer pointed out that the correlation between direct smoking and lung cancer is markedly weaker in South Asian women compared to Western demographics. Instead, long-term exposure to secondhand smoke, indoor biomass fuel combustion in poorly ventilated kitchens, and ambient air pollution serve as major contributors.

Recognizing the Early Warning Signs

One of the primary challenges in managing lung cancer is its silent onset. In early stages, pulmonary tumors rarely produce distinct symptoms, leading to late-stage diagnoses when treatment options are less curative.

GCRI experts and public health organizations urge the public to seek immediate medical evaluation if they experience any of the following persistent signs:

• A lingering cough that worsens or lasts longer than three weeks.

• Coughing up blood (hemoptysis) or rust-colored sputum, even in small amounts.

• New or worsening shortness of breath during routine tasks.

• Unexplained chest, shoulder, or back pain that deepens with breathing or coughing.

• Persistent voice hoarseness or chronic respiratory infections like bronchitis.

• Unintended weight loss accompanied by fatigue and loss of appetite.

“A persistent cough should never be dismissed simply as a ‘smoker’s cough’ or seasonal allergy,” notes Dr. Meera Sharma, a senior pulmonologist. “Early clinical evaluation through low-dose CT scans or chest radiography can significantly shift the diagnosis to an earlier, more treatable stage.”

Public Health Implications and Practical Steps

The ongoing rise in cases highlights the necessity of multi-pronged public health strategies. While national tobacco control policies have made strides, experts call for targeted state-level interventions, stricter enforcement of smoke-free public spaces, and expanded access to smoking cessation programs.

Actions for Individuals and Families

1. Eliminate Tobacco Use: Quitting smoking at any age significantly reduces lung cancer risk over time. Seek clinical support or counseling for effective cessation methods.

2. Mitigate Indoor Exposure: Ensure proper kitchen ventilation when using solid biomass fuels, or transition to cleaner LPG fuel alternatives where feasible.

3. Prompt Clinical Assessment: Do not delay seeking care for lingering respiratory symptoms, regardless of whether you have a history of smoking.

Guidance for Healthcare Providers

Clinicians are advised to maintain a high index of suspicion for lung cancer in non-traditional patient demographics, including non-smoking women and individuals exposed to occupational carcinogens or heavy indoor smoke. Routine risk profiling during primary care visits remains critical for early intervention.

Context and Study Limitations

While the data from GCRI provides valuable clinical insights, epidemiologists note certain observational limitations. Hospital-based registry numbers reflect patients who successfully accessed care at a single major oncology referral center. Consequently, an increase in registrations may stem from a combination of expanded hospital capacity, improved regional referral networks, better diagnostic tools, and actual population-level incidence growth.

Nevertheless, the convergent evidence from global health bodies, regional registries, and long-term population studies confirms that curbing tobacco consumption and reducing environmental pollutant exposures remain the most effective tools to reverse the rising burden of lung cancer.

Medical Disclaimer

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.

References

1. Gujarat Cancer and Research Institute. Lung Cancer Patient Registration Update (2021–2025). Reported via NDTV Health, July 31, 2026.